|
|
Fusion IP Plc - Comparative Business Analysis Snapshot
Business Description
Fusion IP Plc Formerly known as Biofusion PLC. The Group's principal activity is commercialising intellectual property that is developed at universities and similar establishments. It focuses on hormone replacement and angiogenesis compounds. The Group also has operations relating to vaccine adjuvants, cytokine therapies, stem cell therapy, drug metabolism and chronic wound therapy.
Competitor Analysis
This analysis compares Fusion IP Plc with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
